Inhibition of drug-metabolizing enzymes by Jingyin granules: implications of herb-drug interactions in antiviral therapy.

Authors:
Zhang F; Liu W; Huang J; Chen QL; Wang DD and 6 more

Journal:
Acta Pharmacol Sin

Publication Year: 2021

DOI:
10.1038/s41401-021-00697-2

PMCID:
PMC8237038

PMID:
34183756

Journal Information

Full Title: Acta Pharmacol Sin

Abbreviation: Acta Pharmacol Sin

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pharmacology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Competing interests The authors declare no competing interests."

Evidence found in paper:

"This work was supported by Shanghai Science and Technology Innovation Action Plans (20S21901500, 20S21900900) supported by Shanghai Science and Technology Committee, the NSF of China (81922070, 81973286), the National Key Research and Development Program of China (2017YFC1700200, 2017YFC1702000), the National Science and Technology Major Project of China (2018ZX09731016), the Three-year Action Plan of Shanghai TCM Development (ZY-(2018-2020)-CCCX-5001), Program of Shanghai Academic/Technology Research Leader (18XD1403600), Shuguang Program (18SG40) & the Project on the Prevention and Treatment of COVID-19 with Chinese and Western Medicines supported by Shanghai Education Development Foundation and Shanghai Municipal Education Commission."

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025